On July 16, 2026 IBRD issued international bonds (US459058MB69) in the amount of USD 1500 mln maturing in 2033. The issues were sold at the price of 100% at par.The bookrunners of the placement were ...

— We have everything you need: full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock ...

— We have everything you need: full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock ...

BARK, Inc. (NYSE: BARK) (“BARK” or the “Company”), a leading global omnichannel brand with a mission to make all dogs happy, today announced it will report its fiscal first quarter 2027 financial ...

A public official recently sold between $15,001 and $50,000 worth of Home Depot stock. Institutional investors show mixed sentiment, with Copeland Capital Management LLC significantly ...

Barclays increased its price target for Carvana (NYSE: CVNA) to $94, maintaining an 'Overweight' rating, signaling a positive investment outlook for the online auto retailer. Despite strong ...

Semiconductor stocks have skyrocketed this year, and Marvell Technologies (NASDAQ: MRVL) has been one of the biggest winners.

Argus Research has raised its price target for Palo Alto Networks to $425.00, suggesting a significant upside potential of 25.66%. Demand for Palo Alto Networks' cybersecurity services is ...

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 21:Astronics Corporation ATRO: This aerospace and defense company has a Zacks Rank #1 and ...

On July 15, 2026 Penguin Solutions issued bonds in the amount of USD 750 mln maturing in 2031. The issues were sold at the price of 100% at par.The bookrunners of the placement were BofA Securities, ...

Like much of the semiconductor sector, ASML (NASDAQ: ASML) was a big winner in the first six months of 2026 as the company benefited from improving sentiment and increasing expectations from the AI ...

Novo Nordisk (NYSE: NVO) is a large drug maker that built its business around treating diabetes. That was how it got into the GLP-1 weight-loss drug space. However, the opportunity for weight-loss ...